Germany-based Sartorius has entered a research partnership with The BASE Facility at The University of Queensl...
Agilent Technologies Inc. has announced the opening of the Dissolution Centre of Excellence (CoE) facility in Crave...
Japanese pharmaceutical firm Takeda has announced that the Committee for Medicinal Products for Human Use...
Waters Corporation has announced a combined investment of up to €6 million with support from IDA Ireland to expand ...
Global life sciences leader Cytiva has acquired CEVEC Pharmaceuticals, a leading German provider of high-performance cel...
Trans-Atlantic private equity healthcare specialist ArchiMed has invested in Bielefeld, Germany-based PlasmidFactory. Fo...
The world-leading medical product and solutions company, Mölnlycke of Sweden has launched a new surgical glove plan...
Why the Sixth Wave - A Virologist View? Experts have warned that the UK is under significant pressure and the sixth wav...
“This appointment reflects our commitment to strategic development and expansion within the gene therapy market. W...
The new generation of tubes "Eppendorf Tubes® BioBased" is made from 90 % "bio-circular", renewable-based feedstook ...
The life science group Sartorius, through its French listed subgroup Sartorius Stedim Biotech, has agreed to acquire 100...
The Coalition for Epidemic Preparedness Innovations (CEPI), Norway has announced funding of up to $375,000 to the UK Med...
Thi Hoang Duong Nguyen, born in 1987, receives the 20,000 euro award for her pioneering work on the structure and functi...
In collaboration with a Japanese firm SBX Corporation, a Swiss-based firm Philip Morris International has deve...
Senator h.c. Udo J. Vetter, Chairman of the Advisory Board and member of the owner family (second from left) along with ...
Pharmapack Europe recognizes excellence and innovation from exhibitors across connected devices, sustainability, supply ...
UK-based Croda has announced that its Health Care division will now become Croda Pharma, bringing its core speciality ex...
QIAGEN has signed agreements to acquire a 96% majority ownership stake in BLIRT SA, a manufacturer of recombinant enzyme...
